VANCOUVER, British Columbia, June 19, 2018 (GLOBE NEWSWIRE) — CROP Infrastructure Corp. (CSE:CROP) (OTCMKTS:CRXPF) (“CROP” or the “Company”) announces its tenant grower “HEMPIRE COMPANY LLC” has received final approval for an additional twenty thousand (20,000) square feet of recreationally licensed canopy space from CalCannabis Cultivation Licensing, a division of the California Department of Food and Agriculture (CDFA) for the Humboldt California Campus as announced on May 9th 2018.
The Humboldt Campus consists of an operational 10,000 square foot medicinal cannabis greenhouse facility and has now obtained an additional 20,000 square feet of recreational licensed canopy. It is expected that the HEMPIRE COMPANY LLC will commence plant population in June/July 2018.
CROP Infrastructure Director & CEO Michael Yorke states: “With the approval of this additional twenty thousand square feet, the Humboldt Campus will triple in size and tenant production capacity. CROP’s portfolio of cannabis infrastructure assets includes two Washington State facilities as well as the Humboldt campus in California, the largest cannabis market in the world. Management will continue to aggressively pursue new world-wide opportunities and expand its portfolio of tenant growers and infrastructure assets in strategic licensed jurisdictions.”
The Company will be hosting an information session for investors at the Vancouver Club at 1:30 PM PST on June 21st. Management will be available to answer questions and present on recent developments and Company milestones.
About Humboldt Holdings LLC
Located in Humboldt County California the property is 8.46 acres and currently houses a 10,000 sqft greenhouse as well as a barn, garage and residence. On site are 5 x 5000 gallon water tanks, a well and pump house and a 30×60 drying shed. The property is zoned for a 10,000 sqft medical and a 20,000 sqft recreational cannabis license.
Crop Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP”.
VANCOUVER, June 19, 2018 /CNW/ – Choom™ (CSE: CHOO) (OTCQB: CHOOF) (the “Company” or “Choom”) an emerging, fully-integrated cannabis company, is pleased to announce that it has advanced the build-out of its cannabis retail store network in Alberta and British Columbia. Choom™ has secured the rights to an additional 7 retail locations in Alberta. Choom has 25 leases in highly strategic and secure locations in Alberta with 24 applications submitted. Choom has also secured 3 additional B.C. retail leases, combined with the existing 7, for a total of 10 retail opportunities in B.C. In all cases, the retail opportunities are subject to all necessary governmental and municipal approvals being granted. This number is expected to grow over the coming months as the Company is currently negotiating additional leases with the intention of submitting applications for retail licenses. The following link will bring you to our retail opportunity map: https://investors.choom.ca/wp-content/uploads/2017/11/ChoomRetailMap.pdf “This is a significant step towards establishing Choom’s strategy to … Continue reading
VANCOUVER, B.C., June 19, 2018 (GLOBE NEWSWIRE) — FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (OTCQB:FNNZF) a royalty company for the U.S. licensed medical cannabis industry, announces that its portfolio investee company, ezGreen Compliance (“ezGreen”), which offers a state-of-the-art enterprise compliance and point-of-sale (POS) software solution for licensed medical cannabis dispensaries and cultivators, has launched its pilot marketing program and has on-boarded multiple customers (dispensaries and cultivators) across the State of California. The pilot program customers are currently utilizing ezGreen’s Health Insurance Portability and Accountability Act (“HIPAA”) Compliance Point-of-Sale Solution and inventory tracking system. Navigating through state-by-state license, tax and compliance issues has been challenging for the legal cannabis industry. ezGreen Compliance helps its customers comply with both the HIPAA and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations. Andriyko Herchak, President and CEO of FinCanna, states, … Continue reading
CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced that Pascal Biosciences, Inc. (TSX-V: PAS) has engaged CFN Media to conduct a 3-month investor and market visibility program to begin on June 19, 2018. “Pascal Biosciences, a Vancouver, BC and Seattle, WA-based biotechnology company, has discovered that certain cannabinoids stimulate the immune system to destroy tumor cells,” said Frank Lane, President of CFN Media. “We’re excited to be working with the company as it looks to bring its R&D-driven products to market to benefit patients.” “At Pascal, we are excited by the potential of cannabinoids for improving cancer treatment. We are looking forward to working with CFN Media to develop our investor visibility,” said Pascal Biosciences CEO and President, Dr. Patrick Gray. CFN Media will leverage its powerful content platform and extensive reach into mainstream and cannabis-focused investor … Continue reading
VANCOUVER, June 19, 2018 /CNW/ – BLOCKStrain TECHNOLOGY CORP. (the “Company” or “BLOCKStrain“) (TSXV: DNAX) is pleased to welcome National Green Biomed Ltd. (“NG Biomed” or “NG”) to its software platform. BLOCKStrain and NG Biomed this week signed a Letter of Intent for adoption of the BLOCKStrain software platform at NG Biomed’s production facility in British Columbia, Canada. NG Biomed is a late-stage applicant to become a licensed producer under the Access to Cannabis for Medical Purposes Regulations in Canada. Under the Letter of Intent signed June 18, 2018, the Parties agree to negotiate the terms of a business relationship through which BLOCKStrain will integrate its core software platform into the operational infrastructure of NG Biomed in order to optimize product testing, genetic verification, supply chain visibility and management of grow operations. Secondly, BLOCKStrain will use its proprietary technology to create a custom platform for NG Biomed that will empower NG Biomed’s clients and partners with the ability to … Continue reading
The global cannabis industry could reach nearly $60 billion by 2027, according to Arcview Market Research, driven by the ongoing legalization of cannabis around the world. While North America has pioneered legalization among G20 nations, many parts of Europe have taken a pro-cannabis stance that could yield an enormous long-term market. Investors may want to take a look at companies focused on this area for potential opportunities. Speakeasy Cannabis Club Ltd. (CSE: EASY) (FFT: 39H), a late-stage applicant under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) represents a compelling opportunity to invest in Europe’s burgeoning cannabis industry. Europe’s $60B Opportunity The European medical cannabis market could be worth about €50 billion, or about $59 billion, once all markets have implemented legislation and market infrastructure to support cannabis, according to Prohibition Partners’ European Cannabis Report. Germany, Poland, and the Netherlands have the most advanced cannabis markets in the … Continue reading
The Canadian cannabis industry is projected to exceed C$22.6 billion over the coming years as adult-use legalization goes into effect and export markets open up. With growing domestic and global demand, some analysts are projecting a shortfall in production that could benefit licensed producers. Many investors have anticipated this and sent valuations sharply higher, which has made the market for newly public companies increasingly appealing to investors. Rapidly Growing Market Canada’s cannabis industry is projected to exceed C$22.6 billion over the coming years, according to Deloitte, driven by the federal-level legalization of medical and adult-use cannabis. According to Health Canada, there are more than one hundred licensed producers in the market today, and more coming online each month. These licensed producers sold more than 6,000 kilograms of dried cannabis and more than 9,000 kilograms of cannabis oil in Q3’17. Health Canada projects that cannabis demand will continue to soar to … Continue reading
Blockchain technology is still relatively unknown, but like the internet in the 1990s, it could revolutionize many industries. A new report by Deloitte hints that retail and consumer packaged goods companies could be the most significant adopters over the next five years, with Wal-Mart Stores Inc. (WMT) and Amazon.com Inc. (AMZN) already experimenting with blockchain to secure their supply chain and reassure customers. Deloitte’s new report, titled “New Tech on the Block: Planning for Blockchain in the Retail and Consumer Goods Industries”, was released earlier this month by Dr. Bryn Walton and Ben Perkins, two experts in the field of retail and consumer goods, as well as Steve Lark, a Deloitte partner in the area of technology consulting. “We expect a tipping point within the next five years, as businesses begin to appreciate blockchains’ ability to track and trace products, record contracts and transactions, and guarantee the movement of information,” … Continue reading
Canada’s upcoming legalization of recreational cannabis could put pressure on cannabis supply, according to a variety of sources, even as many licensed producers ramp up production capacity. Deloitte analysts project that the market could top C$22.6 billion over the coming years, driven by both domestic growth from recreational legalization and growing demand for export from the European Union and other countries around the world. RavenQuest BioMed Inc. (CSE: RQB) is well-positioned to capitalize on these trends with its four-pillar approach to the industry and rapidly growing production portfolio. After moving to acquire another late-stage applicant earlier this month, investors may want to take a closer look at the stock over the coming months. Western Agripharma Acquisition RavenQuest BioMed recently announced a binding letter of intent to acquire Western Agripharma Ltd. and a 15-acre parcel of land for 4,335,294 common shares at $0.85 per share, or roughly $3.7 million in consideration. … Continue reading
The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide later this year. While most of the roughly 100 licensed producers in the market are focused on marketing to men, the market is starting to realize that women actually account for at least half — and possibly a majority — of the overall market. 48North Cannabis Corp. (TSX-V: NRTH) recently began trading on the TSX Venture exchange as the first vertically-integrated house of brands focused on women’s health and wellness in the cannabis industry. As one of the only publicly-traded cannabis companies with a female CEO, the company is uniquely positioned to target this underserved demographic with innovative brands and top-shelf product. Women and Cannabis Men are more likely to use almost all types of illicit drugs, according to the National Institute on Drug Abuse, … Continue reading